Officers (2018 – 2020)
Joseph Biederman, M.D. – President
Chief, Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD
Massachusetts General Hospital
1st Term: 2007 – 2015
President Elect: 2016 – 2018
President: 2018 – 2020
Disclosure | Biography
He has been the recipient of the American Psychiatric Association Blanche Ittelson Award for Excellence in Child Psychiatric Research, the American Academy of Child and Adolescent Psychiatry Charlotte Norbert Rieger Award for Scientific Achievement. He has been inducted into the CHADD “Hall of Fame”. Dr Biederman has also been selected every year since its inception into the “The Best Doctors in America” compilation of the best physicians in the country, and was recently named among the top 1% of psychiatrists by US News and World Report.
Dr. Biederman has been a mentor to more than 15 junior investigators in the field. He is on the editorial board of multiple journals, a reviewer for many Psychiatric journals, and has served as a grant reviewer in the Child Psychopathology and Treatment Review Committee of the NIMH. Dr. Biederman is the author and co-author over 750 scientific articles, 650 scientific abstracts, and 70 book chapters.
In 2000, Dr. Biederman pioneered and established a Stanley Foundation Center at the Massachusetts General Hospital dedicated to the treatment of pediatric bipolar disorder. Dr. Biederman was the recipient of the 1998 NAMI Exemplary Psychiatrist award. He was also the recipient of the 2002 NARSAD Senior Investigator award. Since 2002 Dr. Biederman has been Associate Editor and from 2005-2006 Deputy Editor for Child Psychiatry in Biological Psychiatry, ranked as the third most impactful scientific journal in Psychiatry. In 2005 Dr. Biederman was appointed Chair of the section on ADHD at the World Psychiatric Association. He was also recently selected by the Massachusetts Psychiatric Society Awards committee as the recipient of the 2007 Outstanding Psychiatrist Award for Research. In 2007, Dr. Biederman received the Excellence in Research Award from the New England Council of Child and Adolescent Psychiatry. He was also awarded the Mentorship Award from the Department of Psychiatry at the Massachusetts General Hospital in September. In 2008, the American Society for Adolescent Psychiatry awarded him the William A. Schonfeld Award for outstanding achievement, excellence and dedication throughout his career in Psychiatry.
In October 2007, Dr. Biederman was ranked as the second highest producer of high-impact papers in psychiatry overall throughout the world with 229 papers cited a total of 6769 times over the past 10 years as determined by the Institute for Scientific Information (ISI). The same organization ranked Dr. Biederman at #1 in terms of total citations to his papers published on ADD/ADHD in the past decade. Dr. Biederman's work is supported by multiple federal and pharmaceutical industry grants. In 2009, Dr. Biederman received a Distinguished Service Award for dedication to the optimal care of children with psychiatric disorders and devotion to residency education, awarded by the MGH/McLean Child and Adolescent Psychiatry Residency
Mark Stein, Ph.D., ABPP – Past-President
Professor of Psychiatry & Behavioral Sciences | Pediatrics
Seattle Children’s Hospital
1st Term: 2007 – 2009
Treasurer: 2010 – 2015
President: 2016 – 2018
Past President: 2018 – 2020
Disclosure | Biography
His clinical work and teaching emphasis is on differential diagnoses and multidisciplinary treatment planning of ADHD throughout the lifespan. He has trained hundreds of pediatricians, psychologists, and psychiatrists who have rotated through the HALP and now the PEARL Clinic, and has evaluated thousands of children, adolescents, and adults.
Dr. Stein has over 100 publications, including articles in Journal of the American Academy of Child and Adolescent Psychiatry, Journal of Child Psychiatry and Psychology, Pediatrics, Nature Medicine, and the New England Journal of Medicine. In 1999, he coedited the text book, Attention Deficit and Hyperactivity in Children and Adults. Dr. Stein is on the editorial board for Journal of Attention Disorders and Journal of Child and Adolescent Psychopharmacology. Dr. Stein has received research support from the National Institute of Health, the Smart Family Foundation, and industry.
He has done significant work on medical mimics of ADHD, such a sleep problems and thyroid disease, adaptive dysfunction, dose response and comparative efficacy of ADHD medications, and molecular genetics. Along with collaborators, Drs. Jeffrey Newcorn, Andrea Chronis-Tuscano, Margaret Weiss, and Tanya Froehlich, current work is on treating ADHD in parents, novel treatments, sleep, and personalizing ADHD treatment.
Dr. Stein is a former member of the CHADD National Advisory Board and research editor of Attention magazine. HE has been a board member of APSARD since its founding, and has been on the executive committee for three years, and co-director of the annual meeting for the past 2 years.
Dr. Katzman was trained at the University of Toronto, having first completed his B.Sc. in Psychology and Neuroscience, and subsequently completed his medical training, residency and post-doctoral fellowship.
Clinically, Dr. Katzman’s works primarily focuses on adults with mood and anxiety disorders and has special interests in adults with Attention Deficit Disorders, executive dysfunction and chronic pain. Clinically, Dr. Katzman’s treatment approaches include: pharmacotherapy, Cognitive Behavioural Therapy, as well as Psychodynamic and Mindfulness Based treatments in both group and individual formats.
As an educator, Dr. Katzman has developed training programs for primary care physicians, psychiatrists, psychologists, social workers, occupational therapists, nurses, and complementary and alternative medicine clinicians.
His research focuses on Hypoprefrontality, Executive Dysfunction, Intolerance of Uncertainty and Low Hedonic Tone, as well as Motivation and Energy in relation to the development of comorbidities and treatment resistance.
Dr. Katzman is also a founding member of the Board of Directors for the Anxiety Disorders Association of Canada/Association Canadienne des Troubles Anxieux (ADAC/ACTA), and its founding and current Chair of the Scientific Advisory Board.
He is the chair of a variety of scientific advisory boards, on the editorial board for a number of journals and has published numerous papers in the areas of Anxiety, Mood, Pain and Attention Disorders.
Dr. Seymour is currently an Assistant Professor at the Johns Hopkins University School of Medicine in the Division of Child and Adolescent Psychiatry. As a clinical psychologist and researcher, Dr. Seymour has extensive experience in the assessment and treatment of individuals with ADHD. In 2013, she was awarded the CHADD Young Scientist Research Award for her ADHD research. She has been involved with APSARD for a number of years and in 2016 was awarded the Best Poster distinction at the annual conference. She has also served as a member of the APSARD Awards Committee for the past 2 years.
Broadly, Dr. Seymour’s research focused on elucidating the neurobiological mechanisms underlying emotion dysregulation in individuals with ADHD. Dr. Seymour’s research utilizes affective neuroscience techniques including: computerized behavioral tasks, physiological data and multimodal neuroimaging to better understand emotion regulation deficits in individuals with ADHD. Currently, Dr. Seymour has two grants designed to examine poor frustration tolerance, a particularly impairing form of emotion dysregulation, in children with ADHD. In addition, Dr. Seymour is a co-investigator on a research study examining reward responsiveness as a mechanisms underlying successful treatment of college students with ADHD who engage in problematic alcohol use. For more information about Dr. Seymour's ongoing research projects please visit: http://www.hopkinsmedicine.org/psychiatry/research/volunteers.html or contact LNIR@kennedykrieger.org.
As a clinician, Dr. Seymour is focused on diagnostic clarification of child psychopathology especially for complex cases. She uses research-grade assessment measures including diagnostic interviews, parent, youth and teacher rating scales, and specialty clinician administered rating scales to complete comprehensive diagnostic evaluations.
Board of Directors
Dr. Brown is director of the Pediatric Neuropsychiatry Program, a multidisciplinary clinic for children with complex ADHD, Tourette syndrome, high functioning autism, and genetic disorders. He has been a principal investigator funded by the National Institutes of Mental Health in an international consortium to develop a data bank of well characterized individuals with Tourette syndrome and parents analyzed with whole exome sequencing. In addition, he is a senior clinician in the Sleep Center and Pediatric Regional Epilepsy Program where he has been principal investigator on numerous investigational drug trials.
He is an active member of CNS, AES and AAP (where he served two terms as Chairman of the Section of Neurology) and AAN. He served on the AAP Subcommittee on ADHD which revised guidelines for diagnosis and treatment of ADHD. In addition to peer reviewed research, Dr. Brown’s publications include associate editorship of Schwartz’s Clinical Handbook of Pediatrics, Fifth Edition, as well as all previous editions. He is a member of the editorial board of Pediatric Neurology. Locally, he served for many years as chairman of the Professional Advisory Board and on the executive board of the Epilepsy Foundation of Eastern Pennsylvania. Dr. Brown currently serves on the advisory committee for the Coordinating Center for Children and Youth with Epilepsy for the American Academy of Pediatrics with funding by HRSA and the Maternal Child Health Bureau as well as the data safety committee for the National Institute of Health’s Best Pharmaceutical for Children Act.
Almost 25 years ago he began a collaboration with the future APSARD president Tony Rostain to scientifically and comprehensively address the needs of children with neuropsychiatric problems. Since then, together and individually, they have worked tirelessly with this population. He is convinced that neurologists are crucial members of any effort to address developmental behavioral, emotional and cognitive brain disorders. They are the natural partners of pediatricians and psychiatrists as well as all who support the potential of all children with ADHD and related conditions. He wants to bring the voice of child neurology to APSARD and to promote the importance of APSARD to all child neurologists.
Betsy Busch, M.D., FAAP – Secretary
Associate Clinical Professor of Pediatrics
Tufts University School of Medicine
1st Term: 2007 – 2009
Secretary: 2010 – 2018
2nd Term: 2018 – 2021
Disclosure | Biography
A well-known specialist in the diagnosis and treatment of children, adolescents and young adults with ADHD and related learning and behavioral disorders, Dr. Busch is in demand as a thought leader, clinical expert, dynamic teacher and consultant. She served for 10 years on the Tufts Medical Center Institutional Review Board. She is an experienced clinical researcher and author of numerous scientific publications and online commentaries. Dr. Busch is on the Editorial Board of the Journal of Attention Disorders, and is an invited peer reviewer for a dozen other scientific journals. She has served on Clinical Advisory Boards for Akili Interactive, Alcobra, Ltd., Cephalon, Eli Lilly, Forest Laboratories, Ortho-McNeil-Janssen, Next Wave, NLS Pharma, Pfizer, Rhodes, Shire, Shionogi, Sunovion Pharmaceuticals, and Tris Pharmaceuticals. She is a member of the Scientific Advisory Board for ADHDFund, an international crowdfunding source for ADHD research. She also is a certified examiner for Major-Minor League Baseball and the National Football League.
Dr. Busch has been an active member of APSARD since its inception, and served as the Secretary of the Board of Directors from 2010-2018. She has served on the Executive Committee, was the Co-Chair of the Program Committee, Chair of the Nominating Committee, and she currently serves on APSARD's Education Steering Committee.
In addition to her work for APSARD, Dr. Busch serves as a Trustee of Tufts University and is on the Board of Advisors for the Jonathan M. Tisch College of Citizenship & Public Service at Tufts University. She also is a gubernatorial appointee to the Board of Directors of the Massachusetts Children’s Trust, a private-public partnership dedicated to preventing child maltreatment. Her work in this area was recently recognized by the American Academy of Pediatrics and the National Alliance of Children’s Trust and Prevention Funds when she was honored with the 2015 Ray E. Helfer, M.D. Award.
Dr. Froehlich also enhances care for children with ADHD through teaching and other professional activities. She has served as an invited speaker providing seminars for professionals and workshops for families in international, national, and regional forums. Currently, she serves on the Executive Board for the American Professional Society of ADHD and Related Disorders, co-chairs the Society for Developmental and Behavioral Pediatrics ADHD Special Interest Group, and is an Editorial Board Member for the Journal of Developmental and Behavioral Pediatrics. In addition, Dr. Froehlich has a strong interest in interprofessional training and mentoring. She is site Principal Investigator for a state-funded grant whose mission is train professionals from a variety of disciplines to provide enhanced care for families on Ohio Medicaid, with a special emphasis on care of developmental and mental health conditions. Dr. Froehlich is also supervisor for a Leadership Education in Neurodevelopmental Disorders interdisciplinary trainee group whose project focuses on elucidating the needs of families in homeless shelters. In addition, Dr. Froehlich serves as Associate Director of the Developmental and Behavioral Pediatrics Fellowship as well as the Director of Research Training for the Cincinnati Children’s Hospital Division of Developmental and Behavioral Pediatrics, where she is Associate Professor of Pediatrics.
Dr. Froehlich is a graduate of Yale University School of Medicine. She completed her residency in pediatrics at the Children’s Hospital of Philadelphia, as well as a Developmental-Behavioral Pediatrics and a National Research Service Award fellowship at Cincinnati Children’s Hospital Medical Center.
Dr. Manor authored more than 70 papers on ADHD which have been published in peer reviewed professional journal She co-authored the first professional book in Hebrew about ADHD along with prof. Tyano – now on its fourth printing.
Dr Manor is the chair, and one of the founders, of the Israeli Society of ADHD, which belongs to the Israeli Medical Association She is also among the founders of the “Lines and Thoughts” NPO which has led major modifications in the interaction with various government agencies and which deals with raising the awareness and lowering the stigma of ADHD. At the International level, she is a member of the board of the American professional group for ADHD (APSARD), and a member of the board of the European Professional group for Adult ADHD (ENAA).
- Dr. Manor was a Primary Investigator for the Geha Mental Health Center in research done by the Alcobra and Enzymotec companies
- Was a consultant for Jansen-Cilag, Novartis, Teva and Medison (Israel)
- Was on one-time (specific) advisory boards for Novartis, Medison, Eli-Lilly and Teva (Israel)
Dr. Mattingly graduated Summa Cum Laude in chemical engineering before pursuing his medical degree at Washington University where he received a Fullbright Scholarship. He then completed his psychiatry residency at Washington University and is a diplomate of the American Board of Psychiatry and Neurology. He is board certified in psychiatry with a subspecialty in adolescent psychiatry. Dr. Mattingly has received numerous awards and distinctions including the Academy of Child and Adolescent Psychiatry National Leadership Award, the Upjohn Neuropsychiatry Research Award, and the Southern Psychiatric Association
As a principal investigator in over 300 clinical trials, he has been an invited presenter at numerous national and international medical conferences. Having served as a certified examiner for both the NFL and MLB, Dr. Mattingly also sits on the board of directors for Headway House; a “club house” program for individuals with developmental disabilities and chronic mental health conditions in St Louis. Dr. Mattingly’s work has been published in The Journal of Neuropsychiatry and Clinical Neurosciences, The Journal of Clinical Psychiatry, The Journal of Child and Adolescent Psychiatry, Current Psychiatry, CNS
Spectrums and Postgraduate Medicine.
Dr. Mattingly has dedicated the past 25 years of his career to caring for children, adolescents and adults with ADHD and associated conditions. His work on medical education in ADHD received the “Best Poster Award” at this year’s ADHD World Congress in Vancouver. Most importantly, as a parent of a child with developmental disabilities, Dr. Mattingly understands the ongoing need for improved coordination of research, education and clinical care for our patients and their families.
Dr. Ramsay has authored numerous peer-reviewed professional and scientific articles, research abstracts, as well as many book chapters. He is author of Cognitive Behavioral Therapy for Adult ADHD: An Integrative Psychosocial and Medical Approach (with Dr. Anthony Rostain and published by Routledge, 2008) and Nonmedication Treatments for Adult ADHD: Evaluating Impact of Daily Functioning and Well-Being (American Psychological Association, 2010). More recently, he authored the revised and updated second edition of Cognitive Behavioral Therapy for Adult ADHD: An Integrative Psychosocial and Medical Approach and its companion patient guidebook The Adult ADHD Tool Kit: Using CBT to Facilitate Coping Inside and Out (both with Dr. Anthony Rostain and published by Routledge, 2015).
Dr. Ramsay received the Martin P. Szuba Award for Excellence in Clinical Teaching & Research from the University of Pennsylvania and is a member of the CHADD Hall of Fame. He serves on the continuing education committee of the Pennsylvania Psychological Association, on the editorial board of the Journal of Attention Disorders and is sought out as an ad hoc reviewer for many other journals. He also serves on the Professional Advisory Boards of the Attention Deficit Disorder Association and CHADD. Dr. Ramsay is frequently interviewed by various media outlets regarding issues related to adult ADHD and has lectured across the country and around the world on topics related to the assessment and treatment of ADHD in adults. His professional interests are improving the assessment and psychosocial treatment of adult ADHD. He is also serves as clinical supervisor for many clinicians-in-training through the PENN Adult ADHD Treatment & Research Program.
Dr. Ramsay has been a member of APSARD since 2009 and was elected as an at-large member of the Board of Directors in 2016. He currently serves as Chair of APSARD’s Social Media Committee.
Anthony Rostain, M.D., M.A.
Director of Education, Department of Psychiatry
University of Pennsylvania
1st Term: 2007 – 2011
President: 2012 – 2015
Past President: 2016 – 2018
2nd Term: 2018 – 2021
Disclosure | Biography
Dr. Rostain is the Director of the Adult Development Disorders Unit (Penn Behavioral Health) which includes the Adult ADHD Treatment and Research Program and the Adult Social Learning Disorders Program. He is also Director of The Children's Hospital of Philadelphia Behavioral Health Center’s Developmental Neuropsychiatry Program. Dr. Rostain is also a faculty member in the Center for Neuroscience and Society where he participates in research seminars and teaches about clinical applications and ethical aspects of cognitive neuroscience. Most recently, he has been active in addressing the growing trend toward nonmedical use of stimulants for cognitive enhancement.
Dr. Rostain's research interests have focused on improving clinical outcomes for patients with ADHD and other neuropsychiatric disorders, and in creating effective service systems for high risk children, youth and families. He completed a study of combined medication and cognitive-behavioral therapy (CBT) for adults with ADHD which served as the basis of a textbook on this topic. He is currently involved in studies of differential therapeutic efficacy of medication and CBT, of developmental processes in young adults with ADHD, of predictors of treatment response for patients with co-morbid conditions such as anxiety and substance abuse.
Dr. Rostain holds several leadership positions in national professional organizations. He is President of the American Professional Society of ADHD and Related Disorders (APSARD), is a National Board member of Children and Adults with ADHD (CHADD), and is on the Executive Council of the American Association of Directors of Psychiatry Residency Training (AADPRT) for which he chairs the Model Curriculum Committee. He also recently completed teaching a seminar on Coursera.org called “Pay Attention: ADHD Through the Lifespan.”
Dr. Solanto’s research on the cognitive and behavioral functioning of children with ADHD, the effects of psychostimulants, and characteristics of the subtypes of ADHD has been supported by grants from the National Institute of Neurological Diseases, the
National Institute of Mental Health, and the National Institute of Child Health and Human Development. Dr. Solanto has also worked extensively with adults with ADHD. She developed a novel cognitive-behavioral intervention which targets problems of timemanagement and organization in adults with ADHD and which was the focus of an NIMH-sponsored treatment efficacy study, published in the American Journal of Psychiatry. The manual for therapists, titled Cognitive-Behavioral Treatment of Adult
ADHD: Targeting Executive Dysfunction was published in 2011 (Guilford Press).
Dr. Solanto is active in clinical work with adults and children, and in the training of psychiatrists and psychologists to diagnose and treat AD/HD and related disorders. She has conducted workshops with parents and teachers concerning identification and treatment of children with AD/HD, and has presented to adult self-help organizations on strategies to improve organization and self-management. Dr. Solanto has published numerous scholarly papers concerning ADHD in children and adults and is a frequent reviewer for professional journals. She has served as a grant reviewer for NIMH. Currently, she is a member of the editorial boards of the Journal of Attention Disorders, ADHD Attention Deficit and Hyperactivity Disorders, and The ADHD Report. She serves on the professional advisory boards of CHADD (Children and Adults with ADHD) and NCLD (National Center for Learning Disabilities), and the Board of Directors of APSARD (American Professional Society for ADHD and Related Disorders). Dr. Solanto edited a book (with Amy Arnsten and Xavier Castellanos) titled: Stimulant Drugs and ADHD: Basic and Clinical Neuroscience, (Oxford University Press), which is an investigation of the mechanisms of action of stimulants in ADHD.
Dr. Waite has served as a Board of Director for the International Society for Psychiatric Mental Health Nurses Foundation Board, Mental Health America of Southeastern PA, Southeastern Pennsylvania Area Black Nurses Association, National Attention Deficit Disorder Association, and the Black Women’s Health Alliance. Currently, Dr. Waite serves as a Board of Director for Corporate Trinity Health, which serves people in 21states with 82 hospitals; 89 continuing care facilities, home health, and hospice programs. She is also on several editorial boards for nursing and interdisciplinary journals.